- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/86 - Oxygen atoms
Patent holdings for IPC class C07D 211/86
Total number of patents in this class: 150
10-year publication summary
|
11
|
15
|
24
|
11
|
6
|
8
|
12
|
4
|
6
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4898 |
12 |
| Shionogi & Co., Ltd. | 854 |
8 |
| Mitsui Chemicals Agro, Inc. | 88 |
7 |
| ViiV Healthcare Company | 154 |
6 |
| Epizyme, Inc. | 370 |
5 |
| F. Hoffmann-La Roche AG | 7925 |
4 |
| Genentech, Inc. | 3976 |
4 |
| Arcus Biosciences, Inc. | 138 |
4 |
| Unichem Laboratories Limited | 102 |
4 |
| Oxular Acquisitions Limited | 21 |
4 |
| Janssen Pharmaceuticals, Inc. | 433 |
3 |
| Syngenta Participations AG | 1903 |
3 |
| Nitto Denko Corporation | 8231 |
3 |
| C4 Theraprutics, Inc. | 56 |
3 |
| Huscion Co., Ltd. | 10 |
3 |
| Glaxosmithkline LLC | 537 |
2 |
| The Regents of the University of California | 19918 |
2 |
| AstraZeneca AB | 2909 |
2 |
| Pfizer Inc. | 3387 |
2 |
| California Institute of Technology | 3976 |
2 |
| Other owners | 67 |